QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
Log in
NYSE:EVH

Evolent Health Stock Forecast, Price & News

$19.54
-0.61 (-3.03 %)
(As of 03/1/2021 12:00 AM ET)
Add
Compare
Today's Range
$19.10
Now: $19.54
$20.84
50-Day Range
$16.89
MA: $18.71
$20.80
52-Week Range
$3.50
Now: $19.54
$22.35
Volume1.08 million shs
Average Volume584,450 shs
Market Capitalization$1.68 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.4
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates through two segments, Services and True Health. The Services segment provides value-based care services that include Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows and engages patients; population health performance that delivers patient-centric cost effective care; delivery network alignments; and integrated cost and revenue management solutions. This segment also offers specialty care management solutions that support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation, and specific market dynamics; and comprehensive health plan administrative services that helps providers assemble the complete infrastructure required to operate, manage, and capitalize on a variety of financial and administrative management services. The True Health segment operates a commercial health plan for small and large businesses in New Mexico. The company was founded in 2011 and is headquartered in Arlington, Virginia.
Evolent Health logo

Industry, Sector and Symbol

Industry Management services
Sub-IndustryN/A
CUSIPN/A
Phone571-389-6000
Employees3,400
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$846.38 million
Cash Flow$2.71 per share
Book Value$10.98 per share

Profitability

Net Income$-301,970,000.00

Miscellaneous

Market Cap$1.68 billion
Next Earnings Date5/6/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

1.22 out of 5 stars

Computer And Technology Sector

517th out of 1,527 stocks

Management Services Industry

6th out of 12 stocks

Analyst Opinion: 1.4Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
$19.54
-0.61 (-3.03 %)
(As of 03/1/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive EVH News and Ratings via Email

Sign-up to receive the latest news and ratings for EVH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Evolent Health (NYSE:EVH) Frequently Asked Questions

Is Evolent Health a buy right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last twelve months. There are currently 3 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Evolent Health stock.
View analyst ratings for Evolent Health
or view top-rated stocks.

What stocks does MarketBeat like better than Evolent Health?

Wall Street analysts have given Evolent Health a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Evolent Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Evolent Health's next earnings date?

Evolent Health is scheduled to release its next quarterly earnings announcement on Thursday, May 6th 2021.
View our earnings forecast for Evolent Health
.

How were Evolent Health's earnings last quarter?

Evolent Health, Inc. (NYSE:EVH) issued its quarterly earnings results on Thursday, February, 25th. The technology company reported ($0.01) earnings per share for the quarter, topping the consensus estimate of ($0.10) by $0.09. Evolent Health had a negative trailing twelve-month return on equity of 4.40% and a negative net margin of 52.35%.
View Evolent Health's earnings history
.

How has Evolent Health's stock been impacted by Coronavirus?

Evolent Health's stock was trading at $6.92 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, EVH stock has increased by 182.4% and is now trading at $19.54.
View which stocks have been most impacted by COVID-19
.

What guidance has Evolent Health issued on next quarter's earnings?

Evolent Health updated its FY 2021 After-Hours earnings guidance on Thursday, February, 25th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $830-880 million, compared to the consensus revenue estimate of $940.38 million.

What price target have analysts set for EVH?

10 analysts have issued 1 year price objectives for Evolent Health's shares. Their forecasts range from $8.00 to $27.00. On average, they anticipate Evolent Health's stock price to reach $18.00 in the next year. This suggests that the stock has a possible downside of 7.9%.
View analysts' price targets for Evolent Health
or view top-rated stocks among Wall Street analysts.

Who are Evolent Health's key executives?

Evolent Health's management team includes the following people:
  • Mr. Frank John Williams, Co-Founder & Exec. Chairman (Age 55, Pay $903k)
  • Mr. Seth Barrie Blackley, Co-Founder, CEO & Director (Age 42, Pay $652.67k)
  • Mr. John Paul Johnson, Chief Financial Officer (Age 37, Pay $451.67k)
  • Mr. Jonathan David Weinberg, Chief Legal Officer, Gen. Counsel & Sec. (Age 53, Pay $652.33k)
  • Dr. Norman C. Payson, Advisor (Age 72, Pay $200k)
  • Mr. Steve Tutewohl, Chief Operating Officer (Age 49)
  • Mr. Aammaad Shams, Interim Principal Accounting Officer & Corp. Controller (Age 37)
  • Mr. Bob East, Investor Contact
  • Ms. Jordan Flynn, VP & Chief Compliance Officer
  • Ms. Jessica Somers, Sr. VP of Corp. Devel.

What is Seth Blackley's approval rating as Evolent Health's CEO?

12 employees have rated Evolent Health CEO Seth Blackley on Glassdoor.com. Seth Blackley has an approval rating of 100% among Evolent Health's employees. This puts Seth Blackley in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Evolent Health's key competitors?

What other stocks do shareholders of Evolent Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Evolent Health investors own include CA (CA), BlackRock (BLK), Universal Insurance (UVE), Endologix (ELGX), Advanced Micro Devices (AMD), Energy Transfer (ET), Chipotle Mexican Grill (CMG), Ford Motor (F), Cisco Systems (CSCO) and Heron Therapeutics (HRTX).

When did Evolent Health IPO?

(EVH) raised $150 million in an IPO on Friday, June 5th 2015. The company issued 10,000,000 shares at $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs acted as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

What is Evolent Health's stock symbol?

Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH."

Who are Evolent Health's major shareholders?

Evolent Health's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.53%), Credit Suisse AG (4.78%), Dimensional Fund Advisors LP (4.40%), Bank of New York Mellon Corp (2.35%), Glenmede Trust Co. NA (1.40%) and Nuveen Asset Management LLC (1.14%). Company insiders that own Evolent Health stock include Doug S Aron, Jonathan Weinberg, Kenneth A Samet, Michael D'amato and Seth Blackley.
View institutional ownership trends for Evolent Health
.

Which institutional investors are selling Evolent Health stock?

EVH stock was sold by a variety of institutional investors in the last quarter, including Gabelli Funds LLC, Voloridge Investment Management LLC, Glenmede Trust Co. NA, Royce & Associates LP, Peregrine Capital Management LLC, GSA Capital Partners LLP, Sei Investments Co., and State of Wisconsin Investment Board.
View insider buying and selling activity for Evolent Health
or view top insider-selling stocks.

Which institutional investors are buying Evolent Health stock?

EVH stock was acquired by a variety of institutional investors in the last quarter, including Kennedy Capital Management Inc., Credit Suisse AG, BlackRock Inc., First Trust Advisors LP, Guggenheim Capital LLC, Bank of New York Mellon Corp, Truist Financial Corp, and Hussman Strategic Advisors Inc.. Company insiders that have bought Evolent Health stock in the last two years include Doug S Aron, Kenneth A Samet, Michael D'amato, and Seth Blackley.
View insider buying and selling activity for Evolent Health
or or view top insider-buying stocks.

How do I buy shares of Evolent Health?

Shares of EVH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Evolent Health's stock price today?

One share of EVH stock can currently be purchased for approximately $19.54.

How much money does Evolent Health make?

Evolent Health has a market capitalization of $1.68 billion and generates $846.38 million in revenue each year. The technology company earns $-301,970,000.00 in net income (profit) each year or ($0.91) on an earnings per share basis.

How many employees does Evolent Health have?

Evolent Health employs 3,400 workers across the globe.

What is Evolent Health's official website?

The official website for Evolent Health is www.evolenthealth.com.

Where are Evolent Health's headquarters?

Evolent Health is headquartered at 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203.

How can I contact Evolent Health?

Evolent Health's mailing address is 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203. The technology company can be reached via phone at 571-389-6000 or via email at [email protected]


This page was last updated on 3/1/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.